Protective and pathological roles of nitric oxide in endotoxin shock CE Wright, DD Rees, S Moncada Cardiovascular research 26 (1), 48-57, 1992 | 764 | 1992 |
PI 3-kinase p110β: a new target for antithrombotic therapy SP Jackson, SM Schoenwaelder, I Goncalves, WS Nesbitt, CL Yap, ... Nature medicine 11 (5), 507-514, 2005 | 729 | 2005 |
Regional vasodilation is a prominent feature of the haemodynamic response to endothelin in anaesthetized, spontaneously hypertensive rats CE Wright, JR Fozard European journal of pharmacology 155 (1-2), 201-203, 1988 | 245 | 1988 |
Cardiac tissue engineering in an in vivo vascularized chamber AN Morritt, SK Bortolotto, RJ Dilley, XL Han, AR Kompa, D McCombe, ... Circulation 115 (3), 353-360, 2007 | 239 | 2007 |
Actions of intrathecal ω-conotoxins CVID, GVIA, MVIIA, and morphine in acute and neuropathic pain in the rat DA Scott, CE Wright, JA Angus European journal of pharmacology 451 (3), 279-286, 2002 | 222 | 2002 |
Thrombin overcomes the thrombosis defect associated with platelet GPVI/FcRγ deficiency P Mangin, CL Yap, C Nonne, SA Sturgeon, I Goncalves, Y Yuan, ... Blood 107 (11), 4346-4353, 2006 | 191 | 2006 |
Structure-function relationships of ω-conotoxin GVIA Synthesis, structure, calcium channel binding, and functional assay of alanine-substituted analogues MJ Lew, JP Flinn, PK Pallaghy, R Murphy, SL Whorlow, CE Wright, ... Journal of Biological Chemistry 272 (18), 12014-12023, 1997 | 150 | 1997 |
The biology of vascular endothelial growth factor-B (VEGF-B) AD Nash, M Baca, C Wright, PD Scotney Pulmonary Pharmacology & Therapeutics 19 (1), 61-69, 2006 | 148 | 2006 |
Evidence that CB-1 and CB-2 cannabinoid receptors mediate antinociception in neuropathic pain in the rat DA Scott, CE Wright, JA Angus Pain 109 (1-2), 124-131, 2004 | 145 | 2004 |
Techniques to study the pharmacodynamics of isolated large and small blood vessels JA Angus, CE Wright Journal of pharmacological and toxicological methods 44 (2), 395-407, 2000 | 143 | 2000 |
Synergistic and additive interactions of the cannabinoid agonist CP55, 940 with μ opioid receptor and α2‐adrenoceptor agonists in acute pain models in mice SM Tham, JA Angus, EM Tudor, CE Wright British journal of pharmacology 144 (6), 875-884, 2005 | 127 | 2005 |
Vasoconstrictor responses to vasopressor agents in human pulmonary and radial arteries: an in vitro study. DA Currigan, RJ Hughes, CE Wright, JA Angus, PF Soeding Anesthesiology 121 (5), 930-936, 2014 | 121 | 2014 |
Vascular amplifier properties in renovascular hypertension in conscious rabbits. Hindquarter responses to constrictor and dilator stimuli CE Wright, JA Angus, PI Korner Hypertension 9 (2), 122-131, 1987 | 108 | 1987 |
Effects of N‐, P‐and Q‐type neuronal calcium channel antagonists on mammalian peripheral neurotransmission CE Wright, JA Angus British journal of pharmacology 119 (1), 49-56, 1996 | 101 | 1996 |
A review of local anesthetic cardiotoxicity and treatment with lipid emulsion E Bourne, C Wright, C Royse Local and regional anesthesia, 11-19, 2010 | 93 | 2010 |
CARDIOVASCULAR ACTIONS OF THE VENOM FROM THE IRUKANDJI (CARUKIA BARNESI) JELLYFISH: EFFECTS IN HUMAN, RAT AND GUINEA‐PIG TISSUES IN VITRO AND IN PIGS IN VITRO KD Winkel, J Tibballs, P Molenaar, G Lambert, P Coles, M Ross‐Smith, ... Clinical and experimental pharmacology and physiology 32 (9), 777-788, 2005 | 81 | 2005 |
Persistent depression of contractility and vasodilation with propofol but not with sevoflurane or desflurane in rabbits CF Royse, DFL Liew, CE Wright, AG Royse, JA Angus Anesthesiology: The Journal of the American Society of Anesthesiologists 108 …, 2008 | 79 | 2008 |
Cardiovascular and autonomic effects of ω‐conotoxins MVIIA and CVID in conscious rabbits and isolated tissue assays CE Wright, AD Robertson, SL Whorlow, JA Angus British journal of pharmacology 131 (7), 1325-1336, 2000 | 66 | 2000 |
Effects of hypertension and hypercholesterolemia on vasodilatation in the rabbit CE Wright, JA Angus Hypertension 8 (5), 361-371, 1986 | 59 | 1986 |
Advantages of a selective β-isoform phosphoinositide 3-kinase antagonist, an anti-thrombotic agent devoid of other cardiovascular actions in the rat SA Sturgeon, C Jones, JA Angus, CE Wright European journal of pharmacology 587 (1-3), 209-215, 2008 | 50 | 2008 |